Monday, 21 October 2019

Quintiles files 19mn shares IPO to raise $790 mn

29 April 2013 | News | By BioSpectrum Bureau

Quintiles IPO offers 19.7 million shares for $36-to-$40 per share

Quintiles IPO offers 19.7 million shares for $36-to-$40 per share

Singapore: Quintiles Transnational Holdings, which is the biggest provider of testing services to drugmakers, has filed for an initial public offering (IPO), seeking to raise $790 million in US.

The company and its shareholders, including TPG Capital and Bain Capital, are offering 19.7 million shares for $36-to-$40 per share, which is equal to about 15 percent of the shares outstanding.

At the midpoint of the range, the market value for Quintiles would be about $4.9 billion, according to data compiled by Bloomberg. The firm decided to sell its shares after its US stocks rose to substantial levels and volatility in the market subsided.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls